A novel compound to overcome influenza drug resistance in endonuclease inhibitors
Crossref DOI link: https://doi.org/10.1007/s11030-023-10659-x
Published Online: 2023-06-02
Published Print: 2024-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ren, Yixin
Wan, Li
Cao, Shuang
Text and Data Mining valid from 2023-06-02
Version of Record valid from 2023-06-02
Article History
Received: 18 January 2023
Accepted: 13 May 2023
First Online: 2 June 2023
Declarations
:
: The authors declare no conflict of interest.